IBC tumor samples have higher mRNA expression of angiogenic factors, including VEGF, Flt-1, Ang1, Ang2, and Tie2, than do non-IBC tumor samples [23,24]. The gene discussed is FLT1; the disease is inflammatory breast carcinoma.